Who are we?
We are an independent Danish enterprise foundation. Characterised as a non-profit organisation, we support philanthropic purposes using funds deriving from our ownership of and investment in companies and other financial assets.
Ownership
Our investment activities as well as our ownership in the Novo Group companies are managed by our fully owned subsidiary Novo Holdings A/S. The objective of Novo Holdings A/S is to ensure that the Foundation obtains a satisfactory financial return on its investments.Governance
As a commercial foundation, we must follow the purpose clause set out in our own statutes. In addition, we are subject to the Danish Commercial Foundations Act, which means that the Danish Business Authority oversees our activities.Societal goals
Through its philanthropic and business activities, the foundation aims to make contributions that benefit people and society.Our History
Our history dates back to 1922, when Nobel Prize winner August Krogh returned from the USA and Canada with the license to produce insulin in the Scandinavian countries. This marked the beginning of the development of world-class diabetes medicine, a Danish business and export success story, and the establishment of foundations that, over the years, merged into what is today known as the Novo Nordisk Foundation.Executive Management
Led by the Foundation’s CEO, our Executive Management is responsible for ensuring that the decisions of the Board of Directors are implemented and for monitoring and following up on the Foundation’s activities.Board of Directors
The Board of Directors of the Foundation has ten members, of which seven are elected annually under the Articles of Association, and three are employee board members elected every four years.Employees
Do you need to get hold of one of our colleagues in the Foundation? Click here to see our contact list.